SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Bright Health Group, Inc. (BHG) .
Criteria proven by this page:
- VALUE (100/100, Pass) — analyst target implies upside (+510.6%).
- Analyst consensus target $99.84 (+510.6% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 35/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — BHG
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.14
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-22.65
Book Value / Share$0.00
Revenue / Share$113.87
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Analyst Target$99.84 (+510.6%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2018 |
$-37.97 |
$130.63M |
$-62.64M |
-48% |
| 2019 |
$-79.52 |
$280.67M |
$-133.69M |
-47.6% |
| 2020 |
$-145.94 |
$1.21B |
$-248.44M |
-20.6% |
| 2021 |
$-240.33 |
$4.03B |
$-1.18B |
-29.2% |
| 2022 |
$-81.08 |
$2.41B |
$-637.97M |
-26.4% |
| 2023 |
$-150.94 |
$1.16B |
$-1.2B |
-103.4% |
| 2024 |
$-22.65 |
$936.66M |
$-186.33M |
-19.9% |
